# Splink

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/splink

- Industry: Healthcare IT
- Headquarters: Tokyo, Japan
- Website: www.splinkns.com
- Total disclosed funding: $13M
- Latest round: Series B (Nov 17, 2021)
- Investors on record: 4

## About

Based in Japan, Splink, Inc. specializes in cloud-based brain healthcare solutions, offering innovative tools to assess and enhance cognitive function for individuals and healthcare providers alike.Splink, Inc. was founded in 2017 in Tokyo, Japan, focusing on advancing brain healthcare technology. The company has successfully completed 2 funding deals, with the most recent being a Series B funding round in November 2021, raising JPY 1.03 billion from investors including Hakuhodo DY Holdings and Mitsubishi UFJ Capital. Splink has not undergone any major pivots in its business strategy since its inception and currently operates without any known subsidiaries. The current valuation of the company stands at JPY 9,302.09 million.Splink specializes in brain healthcare, offering innovative solutions aimed at addressing cognitive decline and dementia. Their core products include the 'CQ test®,' a self-assessment cognitive function measurement tool, and a brain check-up program that employs AI technology to analyze MRI images of the hippocampus. Additionally, Splink developed Braineer, a medical device program that quantitatively analyzes brain volume reduction from MRI data. These services are utilized by healthcare providers, patients, and caregivers across Japan and potential markets in the United States and Europe.Splink generates revenue through various channels, focusing on B2B partnerships with healthcare institutions and direct sales to consumers. Their flagship products, such as the CQ test® and the Braineer program, are offered on a subscription basis, enabling clients to access ongoing cognitive assessments. The pricing structure facilitates widespread adoption among individual users and institutional clients, aligning with government initiatives and startup support programs to reinforce its revenue model.Splink, Inc. aims to utilize the JPY 1.03 billion raised in Series B funding to accelerate service provision and invest in new product development specifically targeting dementia solutions. The company plans to expand its offerings and reach new markets, particularly in the United States and Europe, by leveraging innovative technologies. The funding will support the development of upcoming products designed to enhance brain health assessment and monitoring.

## Funding rounds

- Series B, Nov 17, 2021, $9.1M — JAFCO Group, Hakuhodo DY Holdings, Mitsubishi UFJ Capital, Tokio Marine & Nichido Fire Insurance Company
- Series A, Apr 1, 2019, $3.6M — JAFCO Group

## Investors

- JAFCO Group (https://capitalatlas.ai/funds/jafco-group) — Series A, Series B
- Hakuhodo DY Holdings — Series B
- Mitsubishi UFJ Capital (https://capitalatlas.ai/funds/mitsubishi-ufj-capital) — Series B
- Tokio Marine & Nichido Fire Insurance Company — Series B